Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
2.
J Ethnopharmacol ; 104(1-2): 100-3, 2006 Mar 08.
Article in English | MEDLINE | ID: mdl-16226418

ABSTRACT

The roots of Onosma argentatum are used traditionally in Turkey for wound healing and burns. The n-hexane-dichloromethane extract of the roots, and four shikonin derivatives (deoxyshikonin, acetyl shikonin, 3-hydroxy-isovaleryl shikonin and 5,8-O-dimethyl acetyl shikonin) isolated from the n-hexane-dichloromethane extract were investigated for their ability to stimulate the growth of human amnion fibroblasts. A range of concentrations was studied and the extract found to stimulate the growth of human amnion fibroblasts in vitro at 0.1 microg/mL whilst 5,8-O-dimethyl acetyl shikonin had the same effect at 0.05-5 microg/mL, although cytotoxicity was observed at 50 microg/mL for all samples. The extract and all the other isolated compounds showed cytotoxicity at 10 microg/mL with the extract and 3-hydroxy-isovaleryl shikonin showing cytotoxicity at 5 microg/mL. It is suggested that any wound healing effect of the roots of Onosma argentatum might be partly due to an additive effect of the shikonin derivatives present.


Subject(s)
Boraginaceae , Cell Proliferation/drug effects , Fibroblasts/drug effects , Fibroblasts/physiology , Growth Substances/pharmacology , Amnion/cytology , Amnion/drug effects , Amnion/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Fibroblasts/cytology , Growth Substances/isolation & purification , Humans , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Roots
3.
Fitoterapia ; 74(7-8): 682-5, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14630173

ABSTRACT

The n-hexane-dichloromethane (1:1) extract of the roots of Onosma argentatum and the methanol extract (partitioned between water and chloroform, ethyl acetate and n-butanol, respectively), of the underground parts (roots and rhizomes) of Rubia peregrina were tested in vitro for their antioxidant and antimicrobial activities. The highest antioxidant activity (98%) was observed at 0.1% concentration for the roots of O. argentatum. It was 96% at 0.25% concentration on the ethyl acetate fraction of R. peregrina. O. argentatum extract was effective on Staphylococcus aureus, Bacillus subtilis and Escherichia coli. The ethyl acetate and chloroform fractions of R. peregrina were effective on S. aureus and E. coli, respectively. These two species did not have any antifungal activity.


Subject(s)
Anti-Infective Agents/pharmacology , Antioxidants/pharmacology , Boraginaceae , Phytotherapy , Plant Extracts/pharmacology , Rubia , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Antioxidants/administration & dosage , Antioxidants/therapeutic use , Bacillus subtilis/drug effects , Escherichia coli/drug effects , Humans , Microbial Sensitivity Tests , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Plant Roots , Staphylococcus aureus/drug effects
4.
Pediatr Hematol Oncol ; 17(7): 577-83, 2000.
Article in English | MEDLINE | ID: mdl-11033733

ABSTRACT

To assess the clinical significance of AML1/ETO gene detected by nested reverse transcriptase polymerase chain reaction, the outcome of 7 patients with acute myeloblastic leukemia between 3 and 14 years of age were presented. All patients had complete remission (CR) at the end of induction (AML-MRC 10 protocol) and 4 underwent unpurged autologous, 2 allogeneic (from matched siblings) non-T-cell-depleted bone marrow transplantations (BMT) in first CR. One patient died due to allogeneic BMT-related complications, and 4 patients relapsed at 13, 17, 18, and 26 months. Only one patient achieved second CR. All relapsed patients died between 18 and 36 months with resistant disease (n = 3) or infection during salvage chemotherapy (n = 1). Two patients who had autologous BMT are alive and disease free at 44 and 50 months. Although statistical significance could not be shown, event-free survival and overall survival rates of AML1/ETO-positive patients (28.57 and 28.57%, respectively) at 3.5 years were even lower than those of AML1/ETO-negative patients. The results confirm some previous reports that AML1/ETO gene in children and adolescents is not a favorable prognostic factor.


Subject(s)
Leukemia, Myeloid, Acute/genetics , Oncogene Proteins, Fusion/genetics , Transcription Factors/genetics , Adolescent , Bone Marrow Transplantation , Child , Child, Preschool , Combined Modality Therapy , Core Binding Factor Alpha 2 Subunit , Disease-Free Survival , Female , Gene Expression , Humans , Leukemia, Monocytic, Acute/genetics , Leukemia, Monocytic, Acute/metabolism , Leukemia, Monocytic, Acute/therapy , Leukemia, Myeloid, Acute/metabolism , Leukemia, Myeloid, Acute/therapy , Leukemia, Myelomonocytic, Acute/genetics , Leukemia, Myelomonocytic, Acute/metabolism , Leukemia, Myelomonocytic, Acute/therapy , Leukemia, Promyelocytic, Acute/genetics , Leukemia, Promyelocytic, Acute/metabolism , Leukemia, Promyelocytic, Acute/therapy , Male , Oncogene Proteins, Fusion/biosynthesis , RNA, Messenger/analysis , RNA, Messenger/genetics , RUNX1 Translocation Partner 1 Protein , Remission Induction , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/biosynthesis
6.
Chemotherapy ; 46(5): 322-6, 2000.
Article in English | MEDLINE | ID: mdl-10965097

ABSTRACT

BACKGROUND: Accidental intrathecal vincristine (VCR) administration results in severe neurotoxicity, usually fatal in outcome. No specific therapy for initrathecal VCR toxicity has been reported so far. In our recent report, complete in vitro degradation of VCR by hypochlorous acid (HOCl) was demonstrated. METHODS: In this comparative study, we examined the in vivo effectiveness of HOCl in the cerebrospinal fluid of 24 New Zealand rabbits following intracisternal VCR administration. RESULTS: There were no significant clinical or histopathologic abnormalities in the control and HOCl groups; however, multiple necrotic foci on histopathological examination of brain sections in the VCR group were determined. There were significantly lower numbers of necrotic foci in brain sections of rabbits which received HOCl administration than those without therapy. CONCLUSION: Our results indicate that HOCl may reduce VCR neurotoxicity.


Subject(s)
Antineoplastic Agents, Phytogenic/toxicity , Brain/drug effects , Vincristine/toxicity , Animals , Brain/pathology , Hypochlorous Acid/pharmacology , Hypochlorous Acid/therapeutic use , Injections, Spinal , Necrosis , Rabbits , Salvage Therapy
7.
Cytometry ; 42(1): 74-8, 2000 Feb 15.
Article in English | MEDLINE | ID: mdl-10679746

ABSTRACT

Early during apoptosis, there is a reduction in mitochondrial transmembrane potential (MTP) and externalization of phosphatidylserine (PS) in cell membrane prior to eventual cell death. Flow cytometric detection techniques targeting these changes, reduction of DiOC(6)(3) uptake upon the collapse of MTP and annexin V binding to PS have been successfully used to detect apoptotic cells. These methods have given comparable results when cell lines were used. We compared the two different techniques, DiOC(6)(3) uptake and Annexin V-propidium iodide co-labeling in the quantification of cytarabine, vincristine and daunorubicin induced apoptosis on three leukemia cell lines (HL-60, CEM, U937), and bone marrow blasts from 26 children with acute myeloid leukemia, 14 with T cell acute lymphoblastic leukemia. Anti-Fas-induced apoptosis in culture-grown peripheral blood T lymphocytes on 18 samples from 9 children with non-malignant conditions were also studied by these techniques. Our results showed that there is a correlation (P < 0. 05) between the apoptosis rates measured by these two techniques for drug-induced apoptosis in myeloid and lymphoid blasts, and for anti-Fas mAb-induced apoptosis in T lymphocytes. This data suggests that reduction of the MTP and PS externalization may be common to many apoptotic pathways and techniques targeting either of these changes may be used in quantification of apoptosis in different clinical samples.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , Flow Cytometry/methods , T-Lymphocytes/drug effects , Tumor Cells, Cultured/drug effects , Annexin A5 , Antibiotics, Antineoplastic/pharmacology , Antimetabolites, Antineoplastic/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Carbocyanines , Child , Cytarabine/pharmacology , Daunorubicin/pharmacology , Fluorescent Dyes , HL-60 Cells , Humans , Indicators and Reagents , Leukemia/blood , Propidium , U937 Cells , Vincristine/pharmacology
8.
Leukemia ; 14(1): 47-51, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10637476

ABSTRACT

Inherent resistance of myeloblasts to vincristine (VCR) has been related to the activity of myeloperoxidase (MPO) which can degrade VCR in the presence of hydrogen peroxide (H2O2). We investigated the relationship between VCR degradation and hypochlorous acid (HOCl) generation from the reaction of H2O2 with chlorine (Cl) as catalyzed by MPO. A cell-free system, three human leukemia cell lines (CEM/CCRF, HL-60, U937) and 15 bone marrow samples from children with acute myeloid leukemia (AML) were studied. VCR cytotoxicity was evaluated by MTT assay and by quantitative measurement of apoptosis. In vitro levels of VCR in cell-free systems were measured by high performance liquid chromatography (HPLC), and intracellular HOCl levels by oxidation of 5-thio-2-nitrobenzoic acid with the accompanying decrease in the absorbency at 412 nm. VCR was degraded by increasing concentrations of HOCl in cell-free systems and this activity was inhibited by taurine, which is known to block HOCl activity. This finding was confirmed by the VCR cytotoxicity studies on cell lines. The HOCl-producing myeloblasts from patients were resistant to VCR. In five samples out of eight HOCl was also detected extracellularly. These results suggest that oxidation by HOCl may be the final step in VCR degradation catalyzed by MPO through its action on intracellular H2O2 and Cl. Leukemia (2000) 14, 47-51.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Bone Marrow Cells/drug effects , Drug Resistance, Neoplasm , Hypochlorous Acid/metabolism , Leukemia, Myeloid/pathology , Peroxidase/metabolism , Vincristine/pharmacology , Acute Disease , Antineoplastic Agents, Phytogenic/metabolism , Bone Marrow Cells/enzymology , Bone Marrow Cells/metabolism , Humans , Leukemia, Myeloid/metabolism , Tumor Cells, Cultured , Vincristine/metabolism
9.
Turk J Pediatr ; 42(4): 341-3, 2000.
Article in English | MEDLINE | ID: mdl-11196757

ABSTRACT

Lymphangiomyoma is an extremely rare tumor occurring exclusively in women of reproductive age. The tumor is characterized by proliferation of immature smooth muscle along the lymphatic vessels of the abdomen, thorax and lung. Although lymphangiomyoma has been reported in a young girl and a girl infant, none has been reported in boys. We report herein a case of lymphangiomyoma in a two-year-old boy. The unusual presentation in this patient was that the tumor arose from the small bowel mesentery without any evidence of lung involvement. The tumor was extirpated and lymphangiomyomatosis was confirmed pathologically.


Subject(s)
Intestinal Neoplasms , Intestine, Small , Lymphangiomyoma , Protein-Losing Enteropathies/etiology , Anastomosis, Surgical , Humans , Infant , Intestinal Neoplasms/complications , Intestinal Neoplasms/pathology , Intestinal Neoplasms/surgery , Lymphangiomyoma/complications , Lymphangiomyoma/pathology , Lymphangiomyoma/surgery , Male , Tomography, X-Ray Computed
10.
Clin Lab Haematol ; 22(6): 373-5, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11318806

ABSTRACT

Brucellosis can present initially with its haematological findings including anaemia, leukopenia, and thrombocytopenia and may mimic primary haematological diseases. We present two patients with complaints of severe epistaxis and isolated thrombocytopenia which was initially diagnosed as idiopathic thrombocytopenic purpura but which was finally attributed to brucellosis. Their platelet count reverted to normal within 2-3 weeks of initiating antibrucellosis treatment with recovery from the disease.


Subject(s)
Brucella melitensis/isolation & purification , Brucellosis/complications , Epistaxis/etiology , Thrombocytopenia/etiology , Adolescent , Brucellosis/diagnosis , Diagnosis, Differential , Epistaxis/diagnosis , Female , Humans , Male , Middle Aged , Thrombocytopenia/diagnosis
11.
Turk J Haematol ; 17(4): 183-8, 2000 Dec 05.
Article in English | MEDLINE | ID: mdl-27263635

ABSTRACT

Wilms tumor 1 (WT1) gene is a tumor supressor gene, expressed in malignant and normal hematopoietic progenitor cells. Prognostic significance of this gene in childhood acute lymphoid leukemia (ALL) is not clear. We evaluated the presence of WT1 expression in bone marrow samples of 28 children with de novo ALL at diagnosis by two step RT-PCR. Expression of WT1 gene was detected in 78.5% of patients. There was no correlation between WT1 gene expression and age, sex, FAB type, leukocyte count, and presence of t(4;11) and t(9;22). All patients were treated with modified BFM 86 protocol. There was no difference in the complete remission (CR) rate between WT1 positive and negative patients. Event free survival (EFS) and overall survival (OS) of WT1 positive and negative patients were also not significant. We conclude that expression of WT1 gene is not associated with specific characteristics of ALL blast cells and is not a prognostic factor for CR, remission duration and overall survival.

12.
Turk J Haematol ; 17(4): 197-206, 2000 Dec 05.
Article in English | MEDLINE | ID: mdl-27263637

ABSTRACT

BCR/ABL expression, which is the molecular equivalent of the Philadelphia chromosome, is an independent poor risk factor in acute lymphoblastic leukemia (ALL). We used a two-step (nested) reverse transcriptase polimerase chain reaction (RT-PCR) assay to examine BCR/ABL expression in the diagnostic bone marrow specimen of children with ALL, prospectively. Among 75 de novo ALL patients, 4 (%5.3) were found to be BCR/ABL- ositive, whereas 4 of 17 relapsed patients (23.5%) were positive. This preliminary study in Turkish children showed an incidence similar to reports from Europe and the U.S.A. More intensive chemotherapies and allogeneic bone marrow transplantations (BMT) uring the first remission were planned if a donor was available. Out of 8 BCR/ABL-positive patients, complete remission (CR) was achieved in 7 patients and partial remission (PR) was achieved in 1 patient. Three patients underwent allogeneic BMT during the first CR and 1 under went autologous BMT during the first PR. The Kaplan-Meier estimate of vent-free survival (EFS) of BCR/ABL negative de novo ALL patients was 78.36% at 3 years, whereas the EFS of positive patients was 31.25% at 26 ± 6.4 months. Molecular screening for the Philadelphia chromosome should become a part of the routine diagnostic panel in ALL patients in order to predict which patients have a poor prognosis and need tailored therapy.

13.
J Cardiovasc Surg (Torino) ; 40(5): 711-3, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10597009

ABSTRACT

Complete resection of the primary lesion in stage III neuroblastoma improves survival Neuroblastoma has a tendency towards surrounding and infiltrating the large vessels, leading to injuries during tumor resection. We operated on a stage III neuroblastoma, which resulted in the right and left common iliac artery and vein damage. The right common iliac artery and, veins were repaired by end to end anastomosis. There was a long gap between the two ends of the left common iliac artery and it was repaired using a mesenteric vein (marginal vein of the colon) graft. Digital subtraction angiography performed 6 months after the operation did not reveal any stenosis or aneurysmatic changes in the anastomoses. We conclude that short segments of large vessels may be sacrificed during the resection of neuroblastomas invading the vessel wall, and the resulting defects may be repaired by end to end anastomosis, or even by substituting mesenteric vein grafts, for the purpose of total or near total removal


Subject(s)
Abdominal Neoplasms/surgery , Iliac Artery/injuries , Iliac Vein/injuries , Neuroblastoma/surgery , Abdominal Neoplasms/diagnostic imaging , Abdominal Neoplasms/pathology , Anastomosis, Surgical , Angiography, Digital Subtraction , Biocompatible Materials , Blood Vessel Prosthesis Implantation , Female , Humans , Iliac Artery/surgery , Iliac Vein/surgery , Infant , Mesenteric Veins/transplantation , Neoplasm Staging , Neuroblastoma/diagnostic imaging , Neuroblastoma/pathology , Polypropylenes , Radiography, Abdominal , Reoperation , Tomography, X-Ray Computed , Ultrasonography, Doppler
14.
Turk J Haematol ; 16(4): 171-5, 1999 Dec 05.
Article in English | MEDLINE | ID: mdl-27265590

ABSTRACT

Congenital agranulocytosis (Kostmann's Syndrome) is a rare autosomal recessive inherited disorder characterised by severe neutropenia, recurrent infections, and death in early life, with the bone marrow showing a maturation arrenst of myeloid cells at the myelocyte stage. The treatment of Kostmann's Syndrome with G-CSF results in rapid improvement. However, a few unexpected results with the use of G-CSF, were reported. Here, we describe a 7-month-old female with Kostmann's Syndrome who had recurrent skin infections and a large pyogenic infection in the supravulvar region. The patient was treated with G-CSF successfully at low doses. The infectious process and the quality of lite of the patient improved. There was no adverse effect due to the dosage and the duration. Currently bone marrow transplantation is the best way to treat Kostmann's Syndrome. Nevertheless, our experience showed that G-CSF treatment in Kostmann's syndrome was highly effective and successfull on a short term basis.

SELECTION OF CITATIONS
SEARCH DETAIL
...